Psychotropic Medication Adherence among Community-Based Individuals with Developmental Disabilities and Mental Illness

Tan, Xi; Marshall, Vincent D.; Balkrishnan, Rajesh; Patel, Isha; Erickson, Steven R.

doi:10.1080/19315864.2014.959216

Cited by 14 publications

(16 citation statements)

References 45 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Another study of anti-epileptic medication use in adults with developmental disabilities found higher adherence rates among those living in group homes compared with those living in semi-independent settings and those in family homes (Hom et al, 2015). Additionally, in a study of psychotropic medication use among those with developmental disabilities and mental illness, there was a positive association between outpatient visits and adherence, which the authors felt was due to a better support system (Tan et al, 2015). In the general population modifiable factors associated with improved adherence to hypertension management include education, communication, and reducing pill burden (Klootwyk & Sanoski, 2011).…”

Section: Discussionmentioning

confidence: 91%

“…Many strategies have been evaluated to improve anti-hypertensive medication adherence. Some effective strategies include encouraging patients, caregivers, and healthcare providers to work together to set therapeutic goals, design and implement a treatment plan, and adjust based on patient progress (Tan et al, 2015); consistently incorporating regular follow-up with the health care system (Ho et al, 2009); and simplifying the treatment regimen (e.g., use of fixed-dose combination medicines, use of long-acting drugs, increasing day's supply per fill, etc. ; Weber et al, 2014;Ritchey et al, 2016).…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Anti-Hypertensive Medication Use and Factors Related to Adherence Among Adults With Intellectual and Developmental Disabilities

Cyrus¹,

Royer²,

Carroll³

et al. 2019

American Journal on Intellectual and Developmental Disabilities

View full text Add to dashboard Cite

Adults with intellectual and developmental disabilities (IDD) are known to experience significant health disparities; however, few studies have described anti-hypertensive medication adherence in this population. Using administrative data from South Carolina from 2000–2014, we evaluated the odds of adherence to anti-hypertensive medication among a cohort of adults with IDD and hypertension. Approximately half (49.5%) of the study cohort were adherent to anti-hypertensive medication. Those who lived in a supervised residence, had a Medicaid waiver, and had more frequent contact with a primary care provider were more likely to be adherent. Organizations that serve people with IDD have an opportunity to increase adherence by educating these individuals, their family members, and caregivers about the importance of adherence to anti-hypertensive medication.

show abstract

Section: Discussionmentioning

confidence: 91%

Section: Discussionmentioning

confidence: 99%

Anti-Hypertensive Medication Use and Factors Related to Adherence Among Adults With Intellectual and Developmental Disabilities

Cyrus¹,

Royer²,

Carroll³

et al. 2019

American Journal on Intellectual and Developmental Disabilities

View full text Add to dashboard Cite

show abstract

“…However, several sources referred to it, while focusing on other parameters and variables. The information extracted from these sources largely clustered on themes of complexity (Branford et al, 1997; Burrow and Rimmer, 1997), risks (Hom et al, 2015; Rasaratnam et al, 2004; Tan et al, 2015; Van Den Bemt et al, 2007) and team makeup (Ellenor and Frisk, 1977; Van Den Bemt et al, 2007; Venables et al, 2015) with repeated emphasis on education and training (Abbott et al, 2014; Bosner and Belfiore, 2001; Buelow and Shore, 2010; Rasaratnam et al, 2004).…”

Section: Resultsmentioning

confidence: 99%

“…These variances were seen between the records of GPs, consultants and home care services, again highlighting the risks associated with there being several parties to medication management. Although risks associated with disparate documentation (Burrow and Rimmer, 1997) and complexity of processes (Branford et al, 1997; Van Den Bemt et al, 2007) have been noted, the problems of non-adherence were also identified in the literature (Hom et al, 2015; Rasaratnam et al, 2004; Tan et al, 2015). Interestingly, Hom et al (2015) noted that, where there was adequate supervision, non-adherence rates reduced.…”

Section: Resultsmentioning

confidence: 99%

Medication management in intellectual disability settings: A systematic review

Sheerin

Eustace‐Cook

Wuytack

et al. 2019

J Intellect Disabil

View full text Add to dashboard Cite

There is a high level of medication usage among people with intellectual disability due to the presence of significant morbidity and co-morbidities. This review sought to explore medication management and administration in intellectual disability settings, identifying frameworks for practice, analysing whether collaborative practice led to better outcomes, identifying key processes associated with practice, locating tools to support practice and describing metrics for outcome measurement. A systematic review was conducted with analysis of 64 sources which remained following screening and appraisal. Limited evidence was identified with some insight into the processes underpinning medication management and administration. No assessment tools were found, but two potential outcome measures, adherence and errors, were noted. The paucity of guidelines and frameworks is concerning as this is a complex area of practice. There is a need for further practice development and research to be undertaken that takes note of the unique issues that can present in intellectual disability settings.

show abstract

“…They maintained that the focus should be on eradicating stigma, and building a social and psychological atmosphere in which those diagnosed with mental health issues will find meaning and hope in their lives. Tan et al (2015) found that adherent patients have a higher inclination towards outpatient visits and adherence to psychotropic medication because they are provided with a better support system where various outpatient and community services are at their disposal.…”

Section: Client Centred Elements Of Recovery/ Medication Adherence (Smentioning

confidence: 99%

Assessing the Use of Recovery Model for Medication Adherence on Mental Health Patients – A Case Study Analysis

BSc¹

2017

IOSR JNHS

View full text Add to dashboard Cite

This integrative review is aimed at identifying the experiences of mental health patients as well as the perception of health care professionals caring for them with regard to understanding medication adherence and overall treatment using the Recovery Model.The rationale is based on placing increasing emphasis on the Recovery Model; requiring the health care system to provide care based on individual needs. The current trend is for care to seek to promote empowerment and social inclusion.The review further strives to provide insight into how the service users experience care and support in order to assess the extent at which the elements of recovery are embedded in mental health practice.Following extensive searching of the data bases and library resources available and application of the predetermined inclusion /exclusion criteria, fifteen published articles and ten policy guidelines on recovery were reviewed for this work. Two themes emerged: A. The elements of client centred care, (with the sub themes including hope, social inclusion, empowerment and shared decision making) B. The policies guiding recovery. The findings of the review were geared towards assessing the clients' and health care providers' perspective on recovery. Happily, both patients and health professionals share the opinion that the Recovery Model is significant in enhancing treatment, including medication adherence. There may be some variation as to how professionals and patients view recovery in terms application of the Recovery Model but these differences are not within the scope of this review. I. Introduction 1.1 Case Study The reasons for choosing this topic are derived from my experience in placement, on the patients who were described as noncompliant and the perception of the nurses towards these patients. Non-compliances, according to the nurses, will refer to those who did not want to take any medication voluntarily, would hide, spit out or throw their medication in a bin after leaving the medication room, and also those who may fail to take their medication as prescribed. There was a specific case of a 50-year-old lady with depression that sparked my interest in the issues related to medication adherence. She routinely felt reluctant to come for her medication and, whenever she turned up, would choose which medication to take and often hide some in a paper napkin in the palm of her hand. She was often seen the last to save time and had been labeled as-bad‖. The nurses were often stressed and found her behavior frustrating. During handovers and in their notes, they continued to describe the patient as noncompliant. No action plan was made to address the lady's poor adherence and such a need was not incorporated into the care plan. As a student nurse, I found this conflicting with the client-centered approach and began to raise questions as to whether, in a practice situation, recovery could be a tool to support and develop a much better therapeutic relationship with this lady and also to help her to adhere to her medication. In this...

show abstract

Psychotropic Medication Adherence among Community-Based Individuals with Developmental Disabilities and Mental Illness

Cited by 14 publications

References 45 publications

Anti-Hypertensive Medication Use and Factors Related to Adherence Among Adults With Intellectual and Developmental Disabilities

Anti-Hypertensive Medication Use and Factors Related to Adherence Among Adults With Intellectual and Developmental Disabilities

Medication management in intellectual disability settings: A systematic review

Assessing the Use of Recovery Model for Medication Adherence on Mental Health Patients – A Case Study Analysis

Contact Info

Product

Resources

About